Pancreatic Acinar Cell Carcinoma (MSK, JCO 2023)

Summary

Pancreatic Acinar Cell Carcinoma (MSK, JCO 2023) is a study catalogued by cBioPortal DataHub under the cancer-type code paac. EvidenceHelix groups it with pancreas studies.

Study description

Targeted sequencing of pancreatic acinar cell carcinoma tumor and normal samples via MSK-IMPACT.

Text as published in the source's study metadata.

Citation & PubMed

The source lists no citation or PubMed id for this study.

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

paac_msk_jco_2023

Short name

paac_msk_jco_2023

Source cancer-type code

paac

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

The source lists no citation or PubMed id for this study.

Related studies

• Acinar Cell Carcinoma of the Pancreas (JHU, J Pathol 2014)

  Whole exome sequencing of 23 surgically resected pancreatic carcinomas with acinar differentiation and their matched normals.

  PancreasOther published and consortium studiesSource code paacPubMed 1

• Metastatic Pancreatic Neuroendocrine Tumor (MSK, JCO Precis Oncol 2018)

  Targeted sequencing of 96 metastatic pancreatic neuroendocrine tumors from 80 patients and their matched normals using MSK-IMPACT. This data is available under the Creative Commons BY-NC-ND 4.0 license (https://creati…

  PancreasMSK studiesSource code panetPubMed 1

• Pancreatic Adenocarcinoma (MSK, Nat Med 2024)

  Targeted sequencing of 2,336 pancreatic adenocarcinoma samples and their matched normals via MSK-IMPACT platform.

  PancreasMSK studiesSource code pancreasPubMed 1

• Pancreatic Cancer (MSK, Cancer Cell 2024)

  Targeted sequencing of 395 early stage pancreatic cancer cases and their matched normals via MSK-IMPACT. This data is available under the Creative Commons BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-…

  PancreasMSK studiesSource code pancreasPubMed 1

• Pancreatic Neuroendocrine Tumors (MSK, 2023)

  Targeted sequencing of 65 Pancreatic Neuroendocrine tumors/normal pairs via MSK-IMPACT.

  PancreasMSK studiesSource code pancreas

• Cystic Tumor of the Pancreas (Johns Hopkins, PNAS 2011)

  Whole-exome sequencing of major neoplastic cyst types of the pancreas: 8 serous cystadenomas (SCAs), 8 intraductal papillary mucinous neoplasms (IPMNs), 8 mucinous cystic neoplasms (MCNs), and 8 solid pseudopapillary…

  PancreasOther published and consortium studiesSource code pactPubMed 1

• Metastatic Pancreatic Adenocarcinoma (PRINCE Trial, Nat Med. 2022) - iAtlas Harmonized

  Whole-exome sequencing and neoantigen landscape analysis of 93 metastatic pancreatic adenocarcinomas and their matched normals from a randomized phase 2 trial evaluating the efficacy of nivolumab and/or sotigalimab wi…

  PancreasOther published and consortium studiesSource code paadPubMed 1

• Pancreatic Adenocarcinoma (ICGC, Nature 2012)

  Whole-exome sequencing of 99 pancreatic samples and their matched normals.

  PancreasOther published and consortium studiesSource code paadPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.